For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
| Revenues | 0 | 0 | - | - |
| Selling, general and administrative expenses | 207,845 | 187,373 | 493,080.5 | 326,018 |
| Research and development | 25,334 | 80,983 | 112,165.5 | 65,885 |
| Total operating expenses | 233,179 | 268,356 | 605,246 | 391,903 |
| Loss from operations | -233,179 | -268,356 | -605,246 | -391,903 |
| Interest expense | - | - | 8,080.5 | - |
| Gain (loss) on settlement of debt | - | - | 0 | 115,085 |
| Interest expense - related party | - | - | - | 19,231 |
| Interest expense | 30,684 | 25,100 | - | 7,613 |
| Interest expense - related party | 21,731 | 21,731 | 128,551.167 | - |
| Gain (loss) on settlement of debt | 0 | 0 | - | - |
| Total other income (expenses) | -52,415 | -46,831 | 82,008.667 | 88,241 |
| Net (loss) | - | - | - | -303,662 |
| Net loss | -285,594 | -315,187 | -523,237.333 | - |
| Basic and diluted | 0 | 0 | -0.003 | - |
| Weighted average number of shares outstanding | 257,809,759 | 257,139,815 | -124,079,666 | 248,614,744 |
United Health Products, Inc. (UEEC)
United Health Products, Inc. (UEEC)